AEMD | Aethlon Medical, Inc. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	0.3801 - 0.3977
52 Week Range	0.2400 - 2.3500
Beta	2.26
Implied Volatility	536.05%
IV Rank	100.00%
Day's Volume	139,358
Average Volume	854,101
Shares Outstanding	13,962,000
Market Cap	5,443,784
Sector	Healthcare
Industry	Medical - Devices
IPO Date	1999-03-04

Valuation
Profitability
Growth
Health
P/E Ratio	-0.14
Forward P/E Ratio	N/A
EPS	-2.79
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	14
Country	USA
Website	AEMD

Aethlon Medical, Inc., a medical technology company, focuses on developing products to diagnose and treat life and organ threatening diseases in the United States. The company develops Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses from the human circulatory system, including removal of COVID-19 virus, associated variants, and related exosomes. Aethlon Medical, Inc. has a collaboration with the University of Pittsburgh Medical Center Hillman Cancer Center for studies related to head and neck cancer. The company was founded in 1999 and is based in San Diego, California.

AEMD's peers: TIVC, TLIS, BJDX, HSCS, NUWE, BBLG, VVOS, RPID, RMED, SINT, OPGN, NPCE, DCTH, SRDX, OSA, CVRX

*Chart delayed

Analyzing fundamentals for AEMD we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is on medium level and Health is weak. For more detailed analysis please see AEMD Fundamentals page.

Watching at AEMD technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on AEMD Technicals page.